AllergyTalk Episode 65: Is an IgE Vaccine a Future Treatment For Food Allergy?

From AllergyTalk · 32:37

Show by allergytalk

Description: In this episode, we are joined by Dr. Karla Adams, a professor of pediatrics and Program Director for the Allergy and Immunology Fellowship at Wilford Hall. We will be reviewing the July/August issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology. Hosts: Gerald Lee, MD, FACAAI and Shyam Joshi, MD, FACAAI Guest: Karla Adams, MD, FACAAI This episode is eligible for CME credit: Episode 65 Target Audience: This activity is intended for primary care providers, Fellows-in-Training Learning Objectives: After completing this activity, participants should be better able to: Summarize recent key developments in the field of allergy and immunology, and assess how these findings impact clinical practice in allergy/immunology management. Demonstrate practical strategies for implementing current recommendations for allergy and immunology conditions, including specific tools and techniques that can be easily integrated into daily clinical workflows. Evaluate the effectiveness of therapy implementation in their practice and employ strategies to monitor patient outcomes in accordance with the most current allergy and immunology guidelines. Accreditation The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Designation The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Speaker Disclosures Gerald Lee, MD, FACAAI No relevant financial relationships with ineligible companies to disclose Shyam Joshi, MD, FACAAI No relevant financial relationships with ineligible companies to disclose Karla Adams, MD, FACAAI No relevant financial relationships with ineligible companies to disclose Additional Information Articles Reviewed: Intranasal Treatments for Children With Sleep-Disordered Breathing: The MIST+ Randomized Clinical Trial. Association between maternal asthma and impaired infant lung function is diminished by inhaled corticosteroid use in pregnancy. A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice. To read archived issues of AllergyWatch, head over to http://college.acaai.org/publications/allergywatch Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles! Please rate our podcast on Apple Podcasts! Please give us feedback, corrections, and suggestions! Email feedback to: [email protected] ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.

More episodes of AllergyTalk

More episodes

PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.